XPeng Inc.XPEVNYSE
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank50
3Y CAGR-45.5%
5Y CAGR-25.4%
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
-45.5%/yr
Annual compound
5Y CAGR
-25.4%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202422.37%
20231.18%
202226.75%
2021138.38%
2020-16.63%
201996.93%
20180.00%